Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Sector
Healthcare
Industry
Medical - Devices
Employees
344
First IPO Date
August 20, 2021
| Name | Title | Pay | Year Born |
| Guohui Wang | Chairman & Chief Executive Officer | 1.86M | 1979 |
| Kun Zhang | Executive Director | 824,153 | 1977 |
| Jiawei Wei | Senior VP, Chief Marketing Officer, Deputy GM & Executive Director | 1.5M | 1979 |
| Zongyu Xue | Senior Vice President | 0 | 1986 |
| Siu Ying Kwok | Joint Company Secretary | 0 | 1985 |
| Han Zhang | COO, CFO & Joint Company Secretary | 0 | 1987 |
Shanghai HeartCare Medical Technology Corporation Limited is a global enterprise specializing in the research, development, manufacturing, and commercialization of neuro-interventional medical devices. Its extensive product range encompasses devices for ischemic stroke thrombectomy, intracranial stenosis intervention, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access. These medical technologies are utilized for both the prevention and treatment of ischemic stroke, including acute ischemic events and intracranial narrowing, as well as for addressing hemorrhagic stroke. Established in 2016 and previously operating as Shanghai Care Medical Technology Corporation Limited, the company maintains its headquarters in Shanghai, People's Republic of China.